Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Cigna Not Pursuing Humana Combination
Cigna says it is not pursuing deal with rival Humana, shares rise
Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.
Humana Stock Is Tumbling. Cigna Won’t Pursue the Health Insurer.
The health insurer Cigna Group snatched away a lifeline from Humana on Monday morning, telling investors it has no intention of buying its flailing competitor.A potential tie-up between Humana and Cigna had been the great will they/won’t they story line in the healthcare sector over the past year.
Cigna officially confirms it's not pursuing a Humana acquisition
Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a statement on Monday. | Despite reports that merger talks were back on, Cigna officially squashed rumors that it was looking to acquire Humana in a statement on Monday.
Drug Store News
3d
Cigna reportedly not buying Humana
Cigna
said it isn't buying
Humana
, per a Wall Street Journal report, which noted that
Cigna
spoke up because of ongoing ...
The American Journal of Managed Care
9d
Cigna-Humana Resume Megamerger Talks: Impact on Stakeholders, Health Outcomes, and Cost
As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...
Yahoo Finance
4d
Cigna-Humana fallout, Trump 2.0 impact: Catalysts
The show starts by highlighting notable company updates and stock reactions for several top stocks, including
Cigna
(CI), ...
3d
Cigna’s Strategic Prudence Amid Market Underperformance: Hold Rating Justified
Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback